Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer.
Sos, Martin L
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. [electronic resource] - Proceedings of the National Academy of Sciences of the United States of America Oct 2009 - 18351-6 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1091-6490
10.1073/pnas.0907325106 doi
Apoptosis--drug effects
Cell Line, Tumor
Genotype
Humans
MAP Kinase Signaling System--drug effects
Neoplasms--drug therapy
Phosphatidylinositol 3-Kinases--genetics
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. [electronic resource] - Proceedings of the National Academy of Sciences of the United States of America Oct 2009 - 18351-6 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1091-6490
10.1073/pnas.0907325106 doi
Apoptosis--drug effects
Cell Line, Tumor
Genotype
Humans
MAP Kinase Signaling System--drug effects
Neoplasms--drug therapy
Phosphatidylinositol 3-Kinases--genetics
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology